<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37791178</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Cutaneous Intravascular CD-30-Positive Anaplastic Large Cell Lymphoma: A Case Report and Literature Review.</ArticleTitle><Pagination><StartPage>e44450</StartPage><MedlinePgn>e44450</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e44450</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.44450</ELocationID><Abstract><AbstractText>Intravascular cutaneous anaplastic large cell lymphoma (ALCL) is an extremely rare non-Hodgkin lymphoma that proliferates in the lumen of small blood vessels and has a propensity to manifest in the skin. Most reported cases of intravascular lymphoma described in the literature are of large B-cell lymphomas, making T-cell lymphomas incredibly rare. As such, we present the case of an 87-year-old male with primary cutaneous intravascular anaplastic large T-cell lymphoma that initially presented with an erythematous, subcutaneous nodule on the right mid-abdomen. We report the immunohistochemical results showing lymphoma cells staining positively for CD3 and CD30 and lacking expression of anaplastic lymphoma kinase, pan-cytokeratin, CD10, CD20, and SOX10. We also review and compare previously reported cases of intravascular ALCL with primary cutaneous involvement.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Banafshay et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banafshay</LastName><ForeName>Kiana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maldonado</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarbox</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">alk negative</Keyword><Keyword MajorTopicYN="N">anaplastic large cell lymphoma</Keyword><Keyword MajorTopicYN="N">cd30 positive</Keyword><Keyword MajorTopicYN="N">cutaneous t-cell lymphoma</Keyword><Keyword MajorTopicYN="N">t-cell lymphoma</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37791178</ArticleId><ArticleId IdType="pmc">PMC10544129</ArticleId><ArticleId IdType="doi">10.7759/cureus.44450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. Blood. 2019;133:1703&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6473500</ArticleId><ArticleId IdType="pubmed">30635287</ArticleId></ArticleIdList></Reference><Reference><Citation>The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. https://doi.org/10.1182/blood-2011-01-293050. Blood. 2011;117:5019&#x2013;5032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3109529</ArticleId><ArticleId IdType="pubmed">21300984</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Ponzoni M, Campo E, Nakamura S. Blood. 2018;132:1561&#x2013;1567.</Citation><ArticleIdList><ArticleId IdType="pubmed">30111607</ArticleId></ArticleIdList></Reference><Reference><Citation>Unusual variants of intravascular malignant hematopoietic neoplasms: a report of 4 cases and review of the literature. Nguyen GH, Yassin AH, Magro CM. Am J Dermatopathol. 2015;37:360&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803724</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity. Metcalf RA, Bashey S, Wysong A, Kim J, Kim YH, Gratzinger D. Am J Surg Pathol. 2013;37:617&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">23480896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutaneous intravascular anaplastic large cell lymphoma. Wang L, Li C, Gao T. J Cutan Pathol. 2011;38:221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20337769</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutaneous intravascular anaplastic large T-cell lymphoma: a case report and review of the literature. Iacobelli J, Spagnolo DV, Tesfai Y, Giardina TM, Chan JJ, Joske D, Wood BA. Am J Dermatopathol. 2012;34:0&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23023016</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravascular T-cell lymphoma of the vulva, CD30 positive: a case report. Zizi-Sermpetzoglou A, Petrakopoulou N, Tepelenis N, Savvaidou V, Vasilakaki T. https://pubmed.ncbi.nlm.nih.gov/19899424/ Eur J Gynaecol Oncol. 2009;30:586&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">19899424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>